These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 26324781

  • 21. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
    Ren F, Hino K, Yamaguchi Y, Funatsuki K, Hayashi A, Ishiko H, Furutani M, Yamasaki T, Korenaga K, Yamashita S, Konishi T, Okita K.
    J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
    [Abstract] [Full Text] [Related]

  • 22. Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant.
    Ogata N, Zanetti AR, Yu M, Miller RH, Purcell RH.
    J Infect Dis; 1997 Mar; 175(3):511-23. PubMed ID: 9041321
    [Abstract] [Full Text] [Related]

  • 23. DNA vaccines prime CD8+ T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence.
    Fissolo N, Riedl P, Reimann J, Schirmbeck R.
    Eur J Immunol; 2005 Jan; 35(1):117-27. PubMed ID: 15593127
    [Abstract] [Full Text] [Related]

  • 24. Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination.
    Zhu D, Liu L, Yang D, Fu S, Bian Y, Sun Z, He J, Su L, Zhang L, Peng H, Fu YX.
    J Immunol; 2016 Apr 01; 196(7):3079-87. PubMed ID: 26936879
    [Abstract] [Full Text] [Related]

  • 25. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM, Chen S, Al-Mahtab M, Abe M, Hiasa Y, Onji M.
    Antiviral Res; 2012 Oct 01; 96(1):59-64. PubMed ID: 22884884
    [Abstract] [Full Text] [Related]

  • 26. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH, Shin YW, Hong KW, Chang KH, Ryoo KH, Paik SH, Kim JM, Brotman B, Pfahler W, Prince AM.
    Antiviral Res; 2008 Sep 01; 79(3):188-91. PubMed ID: 18479762
    [Abstract] [Full Text] [Related]

  • 27. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
    Michler T, Kosinska AD, Festag J, Bunse T, Su J, Ringelhan M, Imhof H, Grimm D, Steiger K, Mogler C, Heikenwalder M, Michel ML, Guzman CA, Milstein S, Sepp-Lorenzino L, Knolle P, Protzer U.
    Gastroenterology; 2020 May 01; 158(6):1762-1775.e9. PubMed ID: 32001321
    [Abstract] [Full Text] [Related]

  • 28. [Effect of exogenous epitopes of helper T lymphocyte on humoral immunity of HBV S gene DNA immunity].
    Peng XM, Xie DY, Gu L, Huang YS, Gao ZL, Yao JL.
    Zhonghua Yi Xue Za Zhi; 2003 Feb 10; 83(3):232-6. PubMed ID: 12812669
    [Abstract] [Full Text] [Related]

  • 29. DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques.
    Obeng-Adjei N, Hutnick NA, Yan J, Chu JS, Myles DJ, Morrow MP, Sardesai NY, Weiner DB.
    Cancer Gene Ther; 2013 Dec 10; 20(12):652-62. PubMed ID: 24310062
    [Abstract] [Full Text] [Related]

  • 30. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T, Günther M, Bienzle U, Neuhaus R, Jilg W.
    Liver Transpl; 2007 Mar 10; 13(3):434-42. PubMed ID: 17318860
    [Abstract] [Full Text] [Related]

  • 31. Vaccination with a DNA vaccine encoding CD317-targeting HBs antigen elicits enhanced immunity in mice.
    Zhang G, Li X, Liu L, Li J, Chen Q, Huang S, Li Y, Wan X.
    Biochem Biophys Res Commun; 2018 Oct 12; 504(4):865-870. PubMed ID: 30219230
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
    Oka Y, Akbar SM, Horiike N, Joko K, Onji M.
    Immunology; 2001 May 12; 103(1):90-7. PubMed ID: 11380696
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells.
    Roh S, Kim K.
    Microbiol Immunol; 2003 May 12; 47(6):453-60. PubMed ID: 12906106
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.